You must be 21 years or older to access this website. All products are for research use only.
Are you 21 years of age or older?
By entering, you confirm that you are at least 21 years old and agree to our terms of service.
Research insights, product updates, and industry news.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

The cheapest tirzepatide (GLP-2 TZ) for research is rarely the best value. Here is how to balance price against the analytical specifications that determine research utility.

Research-grade GHK-Cu pricing depends on vial size, batch availability, supplier analytical depth, and copper content verification. Here is what to expect in 2026.

GHK-Cu is available in cosmetic skincare formulations over the counter and through Research Use Only research peptide suppliers. The two channels differ in concentration, documentation, and intended use.

GHK-Cu has been studied since 1973 across collagen synthesis, dermal fibroblast research, wound healing, and gene expression. The published literature is the answer to whether the molecule lives up to its reputation.

Why retatrutide outperforms single and dual incretin agonists in preclinical research models comes down to the glucagon receptor component, energy expenditure, and integrated metabolic axis engagement.

Tirzepatide and retatrutide differ in receptor count and downstream pharmacology. This research-context comparison covers mechanism, body composition, and how to choose between them.

Researchers can buy retatrutide (GLP-3 RT) through the Research Use Only research peptide market. The molecule is not FDA approved, but RUO suppliers ship batch-verified material for laboratory work.

Retatrutide is still in clinical development. The way researchers obtain GLP-3 RT for preclinical work is the Research Use Only supply chain, where COA-verified material is sold for laboratory studies.

GLP-1 and GLP-3 differ by the number of receptors targeted. GLP-1 SM (semaglutide) is a single GLP-1 receptor agonist; GLP-3 RT (retatrutide) is a triple GLP-1/GIP/glucagon agonist.

GLP-3 RT and retatrutide refer to the same triple GLP-1/GIP/glucagon receptor agonist research peptide. Here's why two names exist and what it means for sourcing.
Showing 1–12 of 254 posts
Browse our catalog of research-grade peptides. Every product is third-party tested with a COA included. Free shipping on every order.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.